Neuroprotection by tetracyclines
- 31 December 2004
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 25 (12), 609-612
- https://doi.org/10.1016/j.tips.2004.10.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Minocycline safety and tolerability in Huntington diseaseNeurology, 2004
- Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosisNeurology, 2004
- Minocycline reduces gadolinium‐enhancing magnetic resonance imaging lesions in multiple sclerosisAnnals of Neurology, 2004
- Minocycline in Huntington's disease: A pilot studyMovement Disorders, 2004
- Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson DiseaseJournal of Neuroscience, 2002
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2001
- Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of MicrogliaJournal of Neuroscience, 2001
- A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic windowProceedings of the National Academy of Sciences, 1999
- Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemiaProceedings of the National Academy of Sciences, 1998
- Reduction of central nervous system reperfusion injury in rabbits using doxycycline treatment.Stroke, 1994